The AHS Scottsdale Program Co-Chairs, Drs. Dougherty, Friedman, and Powers invite you to attend the upcoming 2024 Scottsdale Headache Symposium! Click on the video to learn more about what is in store for #AHSAZ. Take advantage of early-bird registration savings and register before September 19th here: bit.ly/4dpZGUx #MedEd #Neurology
American Headache Society
Non-profit Organizations
Mount Royal, New Jersey 3,470 followers
The Core Goal of the AHS is to improve the lives of people impacted by migraine and other headache disorders.
About us
The American Headache Society (AHS) is a professional society of health care providers dedicated to the study and treatment of headache and face pain. The Society’s objectives are to promote the exchange of information and ideas concerning the causes and treatments of headache and related painful disorders. Educating physicians, health professionals and the public and encouraging scientific research are the primary functions of this organization. AHS activities include an annual scientific meeting, a comprehensive headache symposium, regional symposia for neurologists and family practice physicians, publication of the journal Headache and sponsorship of the American Migraine Foundation.
- Website
-
https://americanheadachesociety.org
External link for American Headache Society
- Industry
- Non-profit Organizations
- Company size
- 2-10 employees
- Headquarters
- Mount Royal, New Jersey
- Type
- Nonprofit
- Founded
- 1958
Locations
-
Primary
19 Mantua Road
Mount Royal, New Jersey 08061, US
Employees at American Headache Society
-
Jenn Vallimont
Journal Managing Editor
-
Olivia Begasse de Dhaem, M.D., FAHS
Board Certified Neurologist and Headache Specialist
-
Lauren Strauss, DO, FAHS
at VCU Health, Childrens Hospital of Richmond
-
Nada Hindiyeh, MD, FAHS
Neurologist specialized in headache and facial pain. Building the department of clinical and research Headache medicine at Metrodora Institute.
Updates
-
On August 7, 45 programs participated in the 2024 Headache Medicine Fellowship Match for positions starting July 1, 2025. It was a great success with 54 matched applicants and over 87% of open positions filled. Are you interested in pursuing a fellowship in Headache Medicine? Interested residents should visit the AHS Headache Medicine Fellowship webpage to view open positions and contact programs. Visit the website here: bit.ly/3Vh4pQ2 Congratulations again to all who matched in the 2024 #HeadacheMatch! #FellowMatch #HeadacheMedicine
-
After reflecting on the significant achievements and growth of the AHS, the Board of Directors are pleased to share the updated Society Strategic Imperatives which will help guide AHS activities and efforts and showcase the outstanding goals and accomplishments of AHS members and volunteer leaders. From Dr. Todd J. Schwedt, AHS President: "Together, I am confident that we can harness the current momentum and channel it towards realizing these goals. Please share your thoughts as we advance each of these imperatives during the coming years." View the Society's Strategic Imperatives on the AHS website here: bit.ly/3NaQlG6
-
Time is running out to apply to the 2024 AHS Emerging Leaders Program! #EmergingAHS aims to encourage early-career medical professionals to enter and thrive not only in the field of headache medicine but also within the Society. To apply, candidates should be AHS members in good standing for at least 1 year, be within 7 years of having completed a training program or terminal research degree, and commit to attending the 2024 Scottsdale Headache Symposium® and 67th Annual Scientific Meeting in person (expenses paid), as well as a virtual mid-year training forum. Learn more and apply by September 1st here: bit.ly/46w5FF7
-
Early-bird registration is now open to all for the 2024 Scottsdale Headache Symposium! Join us for practical, clinical, evidence-based information on the diagnosis, management and treatment of #headache disorders. Click the link to register and secure your hotel accommodations today: https://lnkd.in/g2Vtv4ce #Neurology #AHSAZ
-
#HeadacheHighlight Plain Language Summary: Post-traumatic headache (PTH) following concussion is a common and potentially disabling condition impacting youth, yet there are no standards for treatment. This article reviews current evidence and identifies knowledge gaps to guide future research. Based on the limited available evidence and expert opinion, we offer a roadmap for the treatment of PTH in children. View the full Headache Journal (Headache: The Journal of Head & Face Pain) article here: bit.ly/3Wzzikf
-
Congratulations to all Fellows and programs who participated this year in #HeadacheMatch 2024! Are you interested in Headache Medicine? The AHS National Headache Medicine Fellowship website serves as a valuable resource for fellowship applicants to find information about current training programs with available openings. Click the link to learn more: bit.ly/3Vh4pQ2 #FellowMatch #HeadacheMedicine
-
AHS members, exclusive early-bird registration for the 2024 Scottsdale Headache Symposium is now available! Join us November 14-17 in Scottsdale, AZ, or live-stream from your home or office and earn AMA PRA Category 1 Credits™. Experience lectures, panel discussions, case-based presentations, and hands-on demonstrations that you can bring back home and apply to clinical practice. Register today to receive an access code to secure the discounted room rate here: bit.ly/4dpZGUx #MedEd #Neurology #AHSAZ
-
Registration is open for the next Live Q&A session of the NEW Mastering Migraine Therapies program. The virtual session will be held Wednesday, September 11 at 7:00 PM ET via AHS Education On Demand. Designed to enhance the MMT program, this hour-long webinar will answer your burning questions from the sessions you watched via Education On Demand. Join expert faculty in headache medicine and enhance your headache knowledge all while earning AMA Category 1 Credit™. Learn more here: bit.ly/46nyHXl #AHSMasteringMigraine
-
#HeadacheHighlights Plain Language Summary: “In this open-label study, we looked at the effects of eptinezumab in a subset of patients with chronic migraine and medication-overuse headache (MOH). Our results showed that after 2 years of treatment with eptinezumab, these patients reported that their headache days had decreased by more than half, their headaches were less severe, and that headaches interfered much less with their lives. Eptinezumab preventive therapy in patients with chronic migraine showed benefits for the group of patients with MOH.” View the full Headache Journal (Headache: The Journal of Head & Face Pain) study here: bit.ly/3SBuHNl